Literature DB >> 9077583

Discriminative characteristics of high and low cocaine administration: effect of other psychostimulants.

M D Schechter1.   

Abstract

Two groups of N/Nih male rats were trained to discriminate saline vehicle from either 2.0 mg/kg (n = 10) or 10.0 mg/kg (n = 10) cocaine in a food-motivated, two-lever operant paradigm. The rats trained at the low-dose cocaine took a significantly longer training period to reach criterion performance than did the high-dose cocaine group. In addition, the ED50 value for the 2.0 mg/kg cocaine-trained animals (0.465 mg/kg) was significantly lower than the ED50 value (2.105 mg/kg) for those animals trained at the 10.0 mg/kg dose of cocaine. This correlation of ED50 values for stimulus generalization decreasing with reduction in training dose was in contrast to the time-course of the two groups when tested from 15 to 240 min post-injection; this experimentation indicated that there was a non-significant difference in half-life for the 2.0 mg/kg (t1/2: 97.1 min) vs. that of the 10.0 mg/kg cocaine-trained group (t1/2: 83.4 min). Generalization tests with other purportedly dopaminergically-active drugs of abuse including 0.05-0.8 mg/kg d-amphetamine, 0.125-1.5 mg/kg methamphetamine and 0.125-1.0 mg/kg methcathinone indicated that the highest doses of each produced generalization and, with the exception of methcathinone, the ED50 values were significantly lower in the low-cocaine trained group. The stimulus properties of cocaine, as they generalize to amphetamine, methamphetamine and methcathinone, can be explained by effects upon central dopaminergic neurons and may be qualitatively different in low-and high-dose trained rats.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9077583     DOI: 10.1016/s0091-3057(96)00301-2

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  8 in total

1.  Comparative Behavioral Pharmacology of Three Pyrrolidine-Containing Synthetic Cathinone Derivatives.

Authors:  Michael B Gatch; Sean B Dolan; Michael J Forster
Journal:  J Pharmacol Exp Ther       Date:  2015-05-21       Impact factor: 4.030

2.  Discriminative-stimulus effects of second generation synthetic cathinones in methamphetamine-trained rats.

Authors:  Jennifer E Naylor; Kevin B Freeman; Bruce E Blough; William L Woolverton; Sally L Huskinson
Journal:  Drug Alcohol Depend       Date:  2015-02-11       Impact factor: 4.492

3.  Discriminative and locomotor effects of five synthetic cathinones in rats and mice.

Authors:  Michael B Gatch; Margaret A Rutledge; Michael J Forster
Journal:  Psychopharmacology (Berl)       Date:  2014-10-05       Impact factor: 4.530

Review 4.  Role of training dose in drug discrimination: a review.

Authors:  Ian P Stolerman; Emma Childs; Matthew M Ford; Kathleen A Grant
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

5.  Abuse-related effects of dual dopamine/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeys.

Authors:  Matthew L Banks; Clayton T Bauer; Bruce E Blough; Richard B Rothman; John S Partilla; Michael H Baumann; S Stevens Negus
Journal:  Exp Clin Psychopharmacol       Date:  2014-05-05       Impact factor: 3.157

6.  Effect of drug-paired exteroceptive stimulus presentations on methamphetamine reinstatement in rats.

Authors:  Keith L Shelton; Patrick M Beardsley
Journal:  Pharmacol Biochem Behav       Date:  2008-04-04       Impact factor: 3.533

Review 7.  Predicting abuse potential of stimulants and other dopaminergic drugs: overview and recommendations.

Authors:  Sally L Huskinson; Jennifer E Naylor; James K Rowlett; Kevin B Freeman
Journal:  Neuropharmacology       Date:  2014-03-22       Impact factor: 5.250

8.  Discriminative stimulus effects of 3,4-methylenedioxypyrovalerone (MDPV) and structurally related synthetic cathinones.

Authors:  Robert W Seaman; Michelle R Doyle; Agnieszka Sulima; Kenner C Rice; Gregory T Collins
Journal:  Behav Pharmacol       Date:  2021-08-01       Impact factor: 2.277

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.